Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

NSE:BIOFILCHEM Revenue

Biofil Chemicals and Pharmaceuticals had revenue of 9.35M INR in the quarter ending December 31, 2025, a decrease of -93.43%. This brings the company's revenue in the last twelve months to 322.66M, down -20.55% year-over-year. In the fiscal year ending March 31, 2025, Biofil Chemicals and Pharmaceuticals had annual revenue of 335.82M, down -16.89%.

• Revenue (ttm): 322.66M
• Revenue Growth: -20.55%
• P/S Ratio: 1.49
• Revenue / Employee: 12.41M
• Employees: 26
• Market Cap: 479.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	335.82M	-68.27M	-16.89%
Mar 31, 2024	404.09M	103.74M	34.54%
Mar 31, 2023	300.35M	76.53M	34.19%
Mar 31, 2022	223.82M	-134.27M	-37.50%
Mar 31, 2021	358.10M	60.42M	20.30%